Pacific Biosciences Of California (PACB) Gross Profit (2010 - 2026)

Pacific Biosciences Of California's Gross Profit history runs 17 years deep, the most recent figure standing at $12.8 million for Q1 2026.

• In Q1 2026, Gross Profit rose 1036.62% year-over-year to $12.8 million; the TTM figure through Mar 2026 stood at $60.0 million (up 143.58% YoY), while the FY2025 annual figure was $45.8 million, up 22.79% from the prior year.
• Gross Profit was $12.8 million for Q1 2026 at Pacific Biosciences Of California, down from $16.6 million in the prior quarter.
• In the past five years, Gross Profit ranged from a high of $17.9 million in Q3 2023 to a low of -$1.4 million in Q1 2025.
• Historically, Gross Profit has averaged $11.6 million across 5 years, with a median of $12.8 million in 2026.
• The sharpest annual moves came in 2025 and 2026: Gross Profit sank 112.15% in 2025, then surged 1036.62% in 2026.
• A 5-year view of Gross Profit shows it stood at $5.1 million in 2022, then jumped by 86.21% to $9.6 million in 2023, then grew by 5.09% to $10.1 million in 2024, then surged by 64.7% to $16.6 million in 2025, then declined by 22.49% to $12.8 million in 2026.
• The last three Gross Profit figures came in at $12.8 million (Q1 2026), $16.6 million (Q4 2025), and $15.9 million (Q3 2025), per Business Quant data.